Lonza | LONN - Selling And Administration Expenses


Lonza reported CHF20.7M in Selling and Administration Expenses for its fiscal semester ending in December of 2022.





Selling And Administration Expenses Change Date
Akzo Nobel EUR 811M 28M Dec/2025
Alcon AG USD 901M 36M Dec/2025
AstraZeneca USD 4.61B 4.46B Dec/2025
BASF EUR 2.21B 13M Dec/2025
Bayer EUR 4.05B 647M Dec/2025
Beiersdorf EUR 271M 51M Dec/2025
Covestro EUR 445M 8M Dec/2025
Demant DKK 6.09B 135M Dec/2025
Fresenius EUR 819M 143M Dec/2025
Fresenius Medical Care EUR 785M 79.56M Dec/2025
Geberit CHF 226M 38.6M Mar/2025
Genmab DKK 208M 60M Dec/2025
Givaudan CHF 561M 25M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
GN Store Nord DKK 1.45B 41M Dec/2025
Hikma Pharmaceutical USD 288M 149M Dec/2025
Johnson Matthey GBP 170M 87M Dec/2025
Merck EUR 1.6B 136M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Philips EUR 1.31B 127M Dec/2025
Roche Holding CHF 7.28B 3.99B Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Smith & Nephew USD 1.42B 65M Dec/2025
Solvay EUR 155M 40M Dec/2025
UCB EUR 1.47B 193M Dec/2025